Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:12883880rdf:typepubmed:Citationlld:pubmed
pubmed-article:12883880lifeskim:mentionsumls-concept:C0007600lld:lifeskim
pubmed-article:12883880lifeskim:mentionsumls-concept:C0086418lld:lifeskim
pubmed-article:12883880lifeskim:mentionsumls-concept:C0376358lld:lifeskim
pubmed-article:12883880lifeskim:mentionsumls-concept:C0668084lld:lifeskim
pubmed-article:12883880lifeskim:mentionsumls-concept:C0334227lld:lifeskim
pubmed-article:12883880lifeskim:mentionsumls-concept:C0205245lld:lifeskim
pubmed-article:12883880lifeskim:mentionsumls-concept:C0017262lld:lifeskim
pubmed-article:12883880lifeskim:mentionsumls-concept:C2911684lld:lifeskim
pubmed-article:12883880lifeskim:mentionsumls-concept:C0185117lld:lifeskim
pubmed-article:12883880pubmed:issue3lld:pubmed
pubmed-article:12883880pubmed:dateCreated2003-7-28lld:pubmed
pubmed-article:12883880pubmed:abstractTextFunctional protease-activated receptors (PAR) are expressed by a variety of malignant cells. In the present study, RT-PCR assays demonstrated the expression of the thrombin receptor PAR-1 mRNA in human prostate cancer cell lines DU 145, LnCAP, and SV40-immortalized human prostate epithelial cell line PNT1A. In contrast, the additional thrombin receptors PAR-3 and PAR-4 were not detected. PAR-1 protein localized to the cellular surface was detected by flow cytometry in all three cell lines. To demonstrate the functional importance of the PAR-1, the effects of different concentrations of thrombin on cell proliferation kinetics were assessed. The treatment of growth-arrested cells with varying concentrations of thrombin demonstrated dose- and time-dependent effects. At low concentration (<0.5 U/ml), thrombin induced proliferation of all prostate-derived cell lines. Thrombin at higher concentration (1.0 U/ml) initially stimulated PNT1A and LnCAP cells to proliferate (time of thrombin application 24 h and 48 h) followed by inhibited growth when assessed after 72 h of incubation. In contrast, 1.0 U/ml thrombin caused earlier inhibition of DU 145 proliferation starting at 48 h of incubation. Our results suggest that PAR-1 mediates the proliferation-modulating effects of thrombin on prostate cancer cells.lld:pubmed
pubmed-article:12883880pubmed:languageenglld:pubmed
pubmed-article:12883880pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:12883880pubmed:citationSubsetIMlld:pubmed
pubmed-article:12883880pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:12883880pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:12883880pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:12883880pubmed:statusMEDLINElld:pubmed
pubmed-article:12883880pubmed:monthJullld:pubmed
pubmed-article:12883880pubmed:issn0300-5623lld:pubmed
pubmed-article:12883880pubmed:authorpubmed-author:Schuff-Werner...lld:pubmed
pubmed-article:12883880pubmed:authorpubmed-author:LiuJianJlld:pubmed
pubmed-article:12883880pubmed:authorpubmed-author:SteinerMichae...lld:pubmed
pubmed-article:12883880pubmed:authorpubmed-author:BastianManuel...lld:pubmed
pubmed-article:12883880pubmed:authorpubmed-author:KohlscheinPet...lld:pubmed
pubmed-article:12883880pubmed:issnTypePrintlld:pubmed
pubmed-article:12883880pubmed:volume31lld:pubmed
pubmed-article:12883880pubmed:ownerNLMlld:pubmed
pubmed-article:12883880pubmed:authorsCompleteYlld:pubmed
pubmed-article:12883880pubmed:pagination163-8lld:pubmed
pubmed-article:12883880pubmed:dateRevised2006-11-15lld:pubmed
pubmed-article:12883880pubmed:meshHeadingpubmed-meshheading:12883880...lld:pubmed
pubmed-article:12883880pubmed:meshHeadingpubmed-meshheading:12883880...lld:pubmed
pubmed-article:12883880pubmed:meshHeadingpubmed-meshheading:12883880...lld:pubmed
pubmed-article:12883880pubmed:meshHeadingpubmed-meshheading:12883880...lld:pubmed
pubmed-article:12883880pubmed:meshHeadingpubmed-meshheading:12883880...lld:pubmed
pubmed-article:12883880pubmed:meshHeadingpubmed-meshheading:12883880...lld:pubmed
pubmed-article:12883880pubmed:meshHeadingpubmed-meshheading:12883880...lld:pubmed
pubmed-article:12883880pubmed:meshHeadingpubmed-meshheading:12883880...lld:pubmed
pubmed-article:12883880pubmed:meshHeadingpubmed-meshheading:12883880...lld:pubmed
pubmed-article:12883880pubmed:meshHeadingpubmed-meshheading:12883880...lld:pubmed
pubmed-article:12883880pubmed:meshHeadingpubmed-meshheading:12883880...lld:pubmed
pubmed-article:12883880pubmed:meshHeadingpubmed-meshheading:12883880...lld:pubmed
pubmed-article:12883880pubmed:meshHeadingpubmed-meshheading:12883880...lld:pubmed
pubmed-article:12883880pubmed:year2003lld:pubmed
pubmed-article:12883880pubmed:articleTitleExpression of functional protease-activated receptor 1 in human prostate cancer cell lines.lld:pubmed
pubmed-article:12883880pubmed:affiliationUniversity of Rostock, Medical Faculty, Institute of Clinical Chemistry and Pathobiochemistry, Ernst-Heydemann-Strasse 6, 18057 Rostock, Germany.lld:pubmed
pubmed-article:12883880pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:12883880pubmed:publicationTypeResearch Support, Non-U.S. Gov'tlld:pubmed
entrez-gene:2149entrezgene:pubmedpubmed-article:12883880lld:entrezgene
http://linkedlifedata.com/r...entrezgene:pubmedpubmed-article:12883880lld:entrezgene
lhgdn:association:47401lhgdn:found_inpubmed-article:12883880lld:lhgdn
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:12883880lld:pubmed